Literature DB >> 24085348

Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson's disease.

Uwe Walter1, Sabine Kleinschmidt, Florian Rimmele, Christian Wunderlich, Irene Gemende, Reiner Benecke, Knut Busse.   

Abstract

The detection of Parkinson's disease (PD) at stages earlier than current diagnostic criteria allow for may increase the efficacy of disease-modifying therapies. Here we studied the relationship between retrospectively reported prodromal non-motor and motor features of PD, their pre-diagnostic presentation to physicians, and the extrapolated potential of an earlier diagnosis of PD considering early diagnostic markers detected at presence. One hundred and fifteen PD patients (41 women; age 63.2 ± 8.6 years) underwent a structured face-to-face interview on 22 prediagnostic symptoms. Present olfactory function, motor symptoms, and substantia nigra hyperechogenicity (SN-h) were assessed using standardized tools. Most frequently self-perceived symptoms in the early and very early prediagnostic phase (>2, >7 years prior to diagnosis) were hyposmia (23, 10 %), musculoskeletal pain (21, 9 %), and depression/anxiety (14, 11 %). In the late prediagnostic phase (≤ 2 years) mild motor signs, especially asymmetric bradykinesia and rest tremor, increasingly dominated the self-perception. In the prediagnostic phase, 99 % of patients consulted a physician because of motor symptoms but only 36 % with non-motor symptoms, mostly pain (20 %), depression/anxiety (9 %), constipation, bladder urgency, insomnia, REM sleep behaviour disorder, sexual dysfunction, and malignant melanoma (each, <6 %). Assuming the potential detectability of present hyposmia, asymmetric motor slowing and SN-h, a triad highly specific for PD, as early as 5 years prior to diagnosis, up to 84 (73 %) patients could have been identified in the prediagnostic phase using their or their physicians' awareness of early symptoms. We conclude that educating the general population and physicians on the importance of distinct prodromal features and applying symptom-specific diagnostic programs can improve the early detection of PD.

Entities:  

Mesh:

Year:  2013        PMID: 24085348     DOI: 10.1007/s00415-013-7125-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild.

Authors:  Bernd Müller; Jan Petter Larsen; Tore Wentzel-Larsen; Geir Olve Skeie; Ole-Bjørn Tysnes
Journal:  Mov Disord       Date:  2010-10-05       Impact factor: 10.338

2.  Olfactory loss may be a first sign of idiopathic Parkinson's disease.

Authors:  Antje Haehner; Thomas Hummel; Cornelia Hummel; Ulrike Sommer; Susann Junghanns; Heinz Reichmann
Journal:  Mov Disord       Date:  2007-04-30       Impact factor: 10.338

Review 3.  A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.

Authors:  Anthony E Lang
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

4.  Parkinson's at risk syndrome: can Parkinson's disease be predicted?

Authors:  Matthew B Stern; Andrew Siderowf
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

5.  Parkinson's disease symptoms: the patient's perspective.

Authors:  Marios Politis; Kit Wu; Sophie Molloy; Peter G Bain; K Ray Chaudhuri; Paola Piccini
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 6.  Meta-analysis of the relationship between Parkinson disease and melanoma.

Authors:  Rui Liu; Xiang Gao; Yi Lu; Honglei Chen
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

7.  Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.

Authors:  Sophie C Flohil; Esther de Vries; H A Martino Neumann; Jan-Willem W Coebergh; Tamar Nijsten
Journal:  Acta Derm Venereol       Date:  2011-01       Impact factor: 4.437

8.  Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.

Authors:  F J Vingerhoets; B J Snow; C S Lee; M Schulzer; E Mak; D B Calne
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

9.  Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Authors:  Daniela Berg; Stefanie Behnke; Klaus Seppi; Jana Godau; Stefanie Lerche; Philipp Mahlknecht; Inga Liepelt-Scarfone; Christoph Pausch; Niko Schneider; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Thomas Gasser; Werner Poewe
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

10.  Common pathogenic pathways in melanoma and Parkinson disease.

Authors:  Coro Paisán-Ruiz; Henry Houlden
Journal:  Neurology       Date:  2010-11-02       Impact factor: 9.910

View more
  8 in total

Review 1.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

2.  Evaluating the Cost-Effectiveness of an Early Detection of Parkinson's Disease through Innovative Technology.

Authors:  David A Munoz; Mehmet Serdar Kilinc; Harriet B Nembhard; Conrad Tucker; Xuemei Huang
Journal:  Eng Econ       Date:  2017-03-22       Impact factor: 0.861

3.  Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Authors:  Uwe Walter; Robert Heilmann; Lara Kaulitz; Tino Just; Bernd Joachim Krause; Reiner Benecke; Jacqueline Höppner
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

4.  Diet pattern and prodromal features of Parkinson disease.

Authors:  Samantha Molsberry; Kjetil Bjornevik; Katherine C Hughes; Brian Healy; Michael Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2020-08-19       Impact factor: 9.910

5.  Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations.

Authors:  Anette Schrag; Zacharias Anastasiou; Gareth Ambler; Alastair Noyce; Kate Walters
Journal:  Mov Disord       Date:  2019-02-08       Impact factor: 10.338

6.  Invalid Self-Assessment of Olfactory Functioning in Parkinson's Disease Patients May Mislead the Neurologist.

Authors:  Nele Schmidt; Laura Paschen; Karsten Witt
Journal:  Parkinsons Dis       Date:  2020-11-16

7.  Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease.

Authors:  Mariam Paracha; Konnor Herbst; Karl Kieburtz; Charles S Venuto
Journal:  Mov Disord Clin Pract       Date:  2022-08-18

8.  Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.

Authors:  R Durcan; L Wiblin; R A Lawson; T K Khoo; A J Yarnall; G W Duncan; D J Brooks; N Pavese; D J Burn
Journal:  Eur J Neurol       Date:  2019-03-01       Impact factor: 6.089

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.